Company intelligence / Profile preview

AFB Fund

Paris, France

Ownership: Private
Development stage: Other

Overview

AFB Fund (the funds managed by Advent France Biotechnology) are early‑stage venture funds investing in European life‑science startups developing innovative therapeutics; the funds themselves do not run clinical programs but back companies from creation through early clinical development.[1]

Modalities: Small moleculeMonoclonal antibodyGene therapyBiologicPeptidesRNA therapy
Industry: Investors

Partnerships

European Investment Fund (EIF)[1]Bpifrance (Fonds national d’amorçage 2)[1]Boehringer Ingelheim Venture Fund[1]Pierre Fabre[1]Unnamed major Asian pharmaceutical company[1]

Beyond the preview

Go deeper on AFB Fund.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on AFB Fund.

Explore the full profile